Irisin Expression and Gene Polymorphism With Peripartum Cardiomyopathy.

S

Sohag University

Status

Enrolling

Conditions

Peripartum Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

NCT04927715
Soh-Med-21-02-26

Details and patient eligibility

About

this is an observertional study aimed at Study the association between the level of irisin expression and (Fibronectin Type III Domain Containing 5 (FDNC5) gene polymorphism in female patients with peripartum cardiomyopathy.

Enrollment

45 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

This study will include females aged between 18 and 45 years old who have been diagnosed and treated clinically for peripartum cardiomyopathy

Exclusion criteria

  • Age less than 18 or more than 45 year old
  • females with dilated cardiomyopathy due to other etiology or outside the time frame of occurrence of peripartum cardiomyopathy

Trial design

45 participants in 2 patient groups

Diseased
Description:
Females with peripartum cardiomyopathy
Control
Description:
Healthy females

Trial contacts and locations

0

Loading...

Central trial contact

Ali mo Altaher, lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems